In Brief: CM Systems 2 Gel
This article was originally published in The Tan Sheet
Executive Summary
CM Systems 2 Gel: Topical pain relieving gel is an unapproved new drug, FDA informs Miami Beach, Fla.-based Colloidal Products in a recent warning letter. The gel is mislabeled as being for "treatment of diabetic neuropathy, shingles, herniated discs, headaches, retention of liquids and `phantom pain,'" the letter notes. In addition, the product fails to identify its active ingredients and does not bear adequate directions for use, FDA says...